微泰醫療-B(02235.HK)被認定為2021年度浙江省“專精特新”中小企業
格隆匯1月7日丨微泰醫療-B(02235.HK)公吿,根據浙江省經濟和信息化廳於近日發佈的《浙江省經濟和信息化廳關於公佈2021年度浙江省“專精特新”中小企業名單的通知》,公司被認定為2021年度浙江省省級“專精特新”中小企業。有效期三年,自2021年12月起算。
省級“專精特新”中小企業是指具備“專業化、精細化、特色化、新穎化”特徵的中小企業,標誌着入選企業在技術、市場、質量、效益等方面具備先進性和示範性,是浙江省優質企業梯度培育體系的重要組成部分。
公司成功入選省級“專精特新”中小企業,是社會各界對公司在糖尿病監測、治療和管理領域長期專注發展、持續創新能力的認可和肯定。入選省級“專精特新”中小企業,公司將成為政府經信部門重點服務的企業,將獲得更多的資源和政策支持,有助於進一步提升公司研發能力和品牌知名度,增強公司在糖尿病監測、治療和管理領域的市場競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.